Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

New data showed that Bimzelx sustained disease control of hidradenitis suppurativa up to 2 years, UCB announced in a press release.“As the first presentation of [Bimzelx (bimekizumab)] data this year, ...

A research team affiliated with UNIST has successfully developed a new porous material for the efficient separation of ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

Methanol, important for the manufacture of many everyday goods and for its green energy potential, may soon be produced faster and more efficiently thanks to a collaboration that included two Oregon ...

GE Vernova's new aeroderivative solution meant to replace older peaker plants has gone online for the first time commercially.

Boston University researchers created a droplet microfluidic component library, enabling quick and affordable device ...

As of 2024, one ingredient has been banned from drinks in the United States. And it's an ingredient you probably had no idea ...